Molecular mechanisms and potential interventions during aging-associated sarcopenia

Mech Ageing Dev. 2024 Dec 10:223:112020. doi: 10.1016/j.mad.2024.112020. Online ahead of print.

Abstract

Sarcopenia, a common condition observed in the elderly, presenting a significant public health challenge due to its high prevalence, insidious onset and diverse systemic effects. Despite ongoing research, the precise etiology of sarcopenia remains elusive. Aging-related processes, which included inflammation, oxidative stress, compromised mitochondrial function and apoptosis, have been implicated in its development. Notably, effective pharmacological treatments for sarcopenia are currently lacking, highlighting the necessity for a deeper understanding of its pathogenesis and causative factors to enable proactive interventions. This article is aimed to provide an extensive overview of the pathogenesis of sarcopenia, along with a summary of current treatment and prevention strategies.

Keywords: Epigenetic; Muscle mass; Myokine; Oxidative stress; Sarcopenia.